Adrenoleukodystrophy National Registry Study
Masonic Cancer Center, University of Minnesota
1,000 participants
May 1, 2019
OBSERVATIONAL
Conditions
Summary
The aim of this registry to understand the natural history and disease progression in ALD and potentially develop bio-markers using the biospecimens collected using this registry.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Collect clinical and epidemiological data through medical record abstraction and self-reported questionnaire survey semi-annually.
Collect research samples, when feasible for those diagnosed with ALD.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03789721